FDA Approves The First Generic Inhaler of Advair Diskus

On January 30, 2019, the FDA approved the first generic version of Advair Diskus. This popular inhaler medication is one of the most commonly used prescriptions for treating Asthma and Chronic Obstruction Pulmonary Disease (COPD). This new license will provide patients with access to more affordable prescriptions. This advancement will also affect the drug market in other parts of the world.

Challenges in Translating an App UI

Many companies never expect to translate their apps, so they often are unprepared to deal with the translation process, resulting in funny or strange translations.

The Pharmaceutical Boom in South Korea

South Korea’s economy is one of the fastest growing in the world. Pharmaceutical research in 2018 alone tripled in production compared to 2017.

The Importance of Going On-Site in Technical Writing

When it comes to boosting a technical document’s value, going on-site with a client is a chance to ask the right questions, feel out pain points, and assess the considerations that technical experts are likely to overlook.

How Deep Does Localization Go?

It is starting to feel inevitable that a truly developed economy should be characterized by diversity—diversity of products and diversity of messaging—in order to meet the diverse needs of modern consumers.

Will AI Replace Translators?

Why hasn’t AI been able to revolutionize the translation industry yet? The answer goes beyond technology.

CSOFT Opens New Office in Boston

CSOFT International has officially opened up the doors to its Boston office last week in the heart of Back Bay at 501 Boylston Street.

Why don’t Chinese manufacturers invest in translation for their manuals?

When it comes to Chinese manufacturers and their technical products, it is quite common to end up with poor-quality documentation. What is the reasoning behind the lack of investment on translation?